The first computer algorithm capable of identifying which tumor cells are driving aggressive cancer growth has been developed by Cancer Research UK-funded scientists from UCL and The Francis Crick ...

The FDA has granted Breakthrough Therapy designation to sacituzumab tirumotecan for patients with advanced or metastatic ...

Merck's (MRK) antibody drug conjugate sac-TMT has received FDA Breakthrough Therapy designation for the treatment of EGFR-mutated lung cancer. Read more here.

The first computer algorithm capable of identifying which tumor cells are driving aggressive cancer growth has been developed ...

This page includes links to articles highlighting the top lung cancer research published on Cancer Therapy Advisor in 2024.

Merck & Co., Inc. (MRK) announced Tuesday that the U.S. Food and Drug Administration has granted Breakthrough Therapy designation to ...

Lung Disease Therapeutics Market. The global lung disease therapeutics market is on an impressive growth trajectory, ...

It involved 511 lung cancer patients with a body mass index (BMI) of 25 or higher (above the threshold for overweight/obesity ...

The primary endpoint of overall survival was missed in the SKYSCRAPER-01 study assessing tiragolumab plus Tecentriq in some ...

The trials are evaluating an individualized neoantigen vaccine with Keytruda as an adjuvant therapy for non-small cell lung cancer.

Institute of Immunobiology-led research has made a significant breakthrough in understanding how the body combats lung cancer ...